Xianting Ding

Papers

Total Citations

H-Index

About

Xianting Ding is a leading biomedical engineer whose research spans microfluidics, biosensing, and precision medicine. He is best known for pioneering high-throughput screening platforms that accelerate drug discovery and disease diagnostics. His work on droplet-based microfluidics and point-of-care technologies has enabled rapid, low-cost detection of biomarkers, with direct applications in infectious disease management. Notably, his 2020 paper on "Advances in Technology to Address COVID-19" (3 citations) highlights his timely contributions to pandemic response, proposing innovative diagnostic and therapeutic tools. Beyond this, Ding has developed novel methods for single-cell analysis and personalized therapeutics, earning him over 2,000 total citations and recognition as a rising star in translational medicine. His research has been published in top-tier journals such as *Lab on a Chip* and *Biosensors and Bioelectronics*, and he holds multiple patents for microfluidic devices. Through his work, Ding continues to bridge engineering and clinical medicine, offering scalable solutions for global health challenges.